Featured
Variants & test impact
SARS-CoV-2 surveillance
Product portfolio & performance

 

Watch these on-demand webinars to learn why Thermo Fisher Scientific is the leading single-source supplier for your COVID-19 testing needs.

 

 

Featured webinars

 

Responding to SARS-CoV-2 Variants, such as Omicron: Detection and Surveillance

Watch on demand ›

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

Watch on demand ›

Molecular Multi-Target Assay Design Coupled with Follow-Up Testing for SARS-CoV-2 Mutations

Watch on demand ›

The importance of simultaneously detecting and differentiating SARS-CoV-2 and influenza during flu season
This event features a product with Emergency Use Authorization. Verify local availability.

Watch on demand ›

Test and differenciate COVID-19, Flu A/B, and RSV with one assay
This event features a product with CE-IVD certification. Verify local availability.

Watch on demand ›

How to Detect New SARS-CoV-2 Mutations

Watch on demand ›

 

Emerging SARS-CoV-2 variants and COVID-19 testing impact

 

Throughout the current global crisis, SARS-CoV-2 has continued to mutate. Discover the importance of these emerging variants and the importance testing plays in the on-demand webinars below.

WebinarCard1

Molecular Multi-Target Assay Design Coupled with Follow-Up Testing for SARS-CoV-2 Mutations

Alan McNally, PhD, Disease Lead for the Milton Keynes Lighthouse Lab UK

Emmanuel André, MD, PhD, Co-Director Infectious Diseases Centre, University Hospital of Leuven

Watch on demand ›

What you'll learn
  • The story of detecting B.1.1.7 (UK variant) from a world-leading epidemiologist
  • The importance of early detection of viral variants and the impact of on global response efforts
  • Molecular diagnostic assay design principles to safeguard against unexpected mutations and to monitor for early indicators of emerging variants
  • The S-gene advantage with B.1.1.7 and the value of a targeted mutation panel as a follow-up test to identify a suspected variant
WebinarCard2

Emerging SARS-CoV-2 Mutations: Impact on TaqPath Assay Performance and its Clinical Implications

Peter De Hoff, PhD, Project Scientist, Department of Reproductive Medicine, Sanford Consortium for Regenerative Medicine, UC San Diego

Watch on demand ›

What you'll learn
  • Automation and miniaturization of clinical SARS-CoV-2 PCR testing
  • Emerging SARS-CoV-2 mutations: Impact on TaqPath assay performance and the implications
WebinarCard3

Molecular Testing, Strain Identification and Quality Control Strategies for COVID-19 Testing

Manohar R. Furtado, PhD, Director R&D, Genetic Testing Solutions, Thermo Fisher Scientific

Watch on demand ›

What you'll learn
  • The importance of testing to lower transmission rates and contain pandemics
  • How mutations emerge and the effect of mutations on SARS-CoV-2 detection assays
  • How to quickly identify emerging mutations and variants

 

SARS-CoV-2 surveillance and mutation confirmation

 

Emerging-Mutation-Surveillance

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Stephen S. Morse, PhD, Columbia University Medical Center

Matthew Avenarius, PhD, Ohio State University Wexner Medical Center

Manoj Ghandi, PhD, Sr. Director, Medical Affairs, Thermo Fisher Scientific

Watch on demand ›

What you'll learn
  • An update on the trending variants and explain the risks of the rise of escape mutants
  • Best practices to establish both global and local surveillance programs

 

COVID-19 test portfolio and product performance

 

Testing remains critically important in the fight against COVID-19. As the leader in COVID-19 testing, Thermo Fisher Scientific continues to produce innovative solutions to meet the demands. Watch the on-demand webinars below to see the products in action.

 

TaqPath COVID-19 tests

 

TaqPath-COVID-Combo

Putting the Applied Biosystems TaqPath COVID-19 kit to the test: clinical performance against the competition

Dr. Ninad Mehta, Medical Microbiology, ARUP Laboratories

Watch on demand ›

What you'll learn
  • Real-world clinical performance of the TaqPath COVID-19 diagnostic test as compared to two other SARS-CoV-2 molecular diagnostic technologies
  • Thermo Fisher Scientific's expanding COVID-19 testing portfolio
TaqPath-COVID-Combo

Responding to the COVID-19 Outbreak: Global Clinical Performance and Development of the Applied Biosystems TaqPath COVID-19 Assay

Paul A. Granato, PhD, DABMM, FAAM, Professor Emeritus of Pathology at SUNY Upstate Medical University Director of Microbiology at Laboratory Alliance of Central New York

Watch on demand ›

What you'll learn
  • Real-world clinical performance of the TaqPath COVID-19 diagnostic test
  • How Thermo Fisher Scientific responded to the SARS-CoV-2 outbreak in the early days of 2020
TaqPath-COVID-Combo

Clinical Laboratory Experience with TaqPath COVID-19 Testing

Scott Hunicke-Smith, PhD, Scientific Director, Clinical Pathology Laboratories

Watch on demand ›

What you'll learn
  • How a large reference laboratory operationalized the use of the TaqPath COVID-19 test
  • How one lab manages of supply chain, preanalytical throughput, analytical throughput, and extreme variances in COVID-19 testing demand

 

Thermo Fisher COVID-19 portfolio of tests

 

D1-New-hero-image-(2)

COVID-19 Diagnostics Testing Solutions Addressing Challenges and Pain Points in the Laboratory

Peter Friebe, PhD, Sr Manager, Molecular Biology, Genetic Testing Solutions, Thermo Fisher Scientific

Watch on demand >

What you'll learn
  • Thermo Fisher’s complete solution to COVID-19 testing
  • How automation can vastly increase throughput
TaqPath-COVI-19-Pooling

After the Surge: Driving Sample Processing Efficiency of COVID-19 Samples 

Weston Hymas, R&D Scientist, ARUP

Manohar R. Furtado, PhD, Director R&D,Genetic Testing Solutions, Thermo FisherScientific

Watch on demand ›

What you'll learn
  • How a SARS-CoV-2 sample pooling protocol can be used to exponentially increase testing efficiency
  • How this method can be implemented in labs for routine processing of samples from populations with low infection rates
Intended use and regulatory statements of products vary. For specific intended use and regulatory statements, please refer to the Instructions for Use (IFU). Product availability by country varies. For product availability in your country, visit the product webpage.
Style Sheet for Global Design System